Open original FDA record ↗Recall record
- FDA identifier
- Z-1160-2008
- Company in FDA record
- Beckman Coulter Inc
- FDA classification date
- Jun 25, 2008
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
False negative results when used to test serum samples (as compared to plasma samples).
Source facts
- Action
- On September 19, 2007, Beckman Coulter mailed to its consignees an Urgent Product Corrective Action Letter informing them that the affected lots of the product were giving false negative results when used to test serum samples (as compared to plasma samples). The letter instructed consignees to discontinue using the affected lots of the product, and to re-test using an EDTA plasma sample if there was any discordance between the results of the serum sample (if it was obtained using an affected lot of the product) as compared with the clinical presentaion of the patient and the results of other diagnostic tests. The letter also instructed consignees to return, within 10 days, the Response Sheet .
- Initiated
- 2007-09-19
- Root cause
- Other
- Terminated
- 2012-05-09
- Distribution
- Worldwide: including USA and Canada.
- Recall number
- Z-1160-2008
- Recall status
- Terminated
- CDRH record ID
- 66575
- FDA classified
- 2008-06-25
- Recall event number
- 45955